Queen Elizabeth Hospital

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Atrial fibrillation1 trial
• Colorectal cancer1 trial
• Kidney cancer1 trial
• Liver and biliary tract cancer1 trial
• Melanoma1 trial
• Neuroendocrine tumours1 trial
• Ovarian cancer1 trial
• Pancreatic cancer1 trial
• Sarcoma1 trial
• Stroke1 trial
• Thyroid cancer1 trial

Phase

• Phase 22 trials

Status

• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• Ariad Pharmaceuticals1 trial
• Boston Scientific Corporation1 trial
• Hoffmann-La Roche1 trial
• The Hong Kong Polytechnic University1 trial

Running trials

• Active, not recruiting

  Concomitant Left Atrial Appendage Closure and Pulsed Field Ablation-Asia

  NCT06686485· Boston Scientific Corporation· Source

• Active, not recruiting

  Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

  NCT02568267· Phase 2· Hoffmann-La Roche· Source

Closed trials

• Completed

  Improving Post-acute Stroke Follow-up Care by Adopting Telecare Consultations in a Nurse-led Clinic

  NCT05183672· The Hong Kong Polytechnic University· Source

• Completed

  A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib

  NCT03535740· Phase 2· Ariad Pharmaceuticals· Source